Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Moemoney42on Apr 16, 2021 12:50pm
121 Views
Post# 33011614

RE:RE:RE:RE:Lets clear up some confusion

RE:RE:RE:RE:Lets clear up some confusion
TheScientist01 wrote: Its likely because Therma thought that clinical trails would be quicker and easier in a country where COVID is unfortunately crazy as hell.. from a clinical experiment stand point, its not a bad move. Dont get me wrong. Im still a slightly disappointed in the last NR and but again the pros outweight the cons here that the product actually works! 

You're kidding right... Ont. has over 4000 new cases a day.. they need a few hundred to complete their data collection... anyone that believes your statement is also "crazy as hell"
<< Previous
Bullboard Posts
Next >>